Neurodyn Life Sciences Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Neurodyn Life Sciences Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11193
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Neurodyn Life Sciences Inc (Neurodyn Life Sciences), formerly Neurodyn Inc is a provider of validation and development of bioactives for neuroprotection and early treatment of neurological diseases. The company’s products include neuroprotectant, memogain, progranulin, and nerve pain treatment. Its Neuroprotectant, is a saponin based bioactive that is used for protection of early stage Parkinson’s disease, Progranulin is a bioactive used for the neuroprotection and treatment of Parkinson’s disease, and nerve pain treatment is a lipophilic compound that acts as an antagonists for sodium and TRP ion channels. Neurodyn Life Sciences develops bioactives for neuroprotection and for treating neurological diseases. The company also provides contract research services for medicinal chemistry. It caters to pharmaceutical and consumer health players. Neurodyn Life Sciences is headquartered in Charlottetown, Canada.

Neurodyn Life Sciences Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Neurodyn Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Neurodyn Life Sciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Neurodyn Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Neurodyn Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Neurodyn Life Sciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Neurodyn Life Sciences Inc, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Neurodyn Acquires Memogain Related Assets From Galantos Pharma 10
Venture Financing 11
Neurodyn Cognition Raises USD0.2 Million in Venture Financing 11
Neurodyn Cognition Raises USD0.4 Million in Venture Financing 12
Neurodyn Raises USD0.4 Million Financing 13
Neurodyn Life Sciences Raises Funds Through Venture Financing 14
Neurodyn Life Sciences Raises USD0.6 Million in Venture Financing 15
Neurodyn Life Sciences Raises USD0.3 Million in Venture Financing 16
Neurodyn Raises US$1.5 Million In Series A Financing 17
Neurodyn Raises US$0.13 Million In Venture Financing 18
Equity Offering 19
Neurodyn Raises USD0.8 Million in Private Placement of Shares 19
Neurodyn Life Sciences Inc – Key Competitors 20
Neurodyn Life Sciences Inc – Key Employees 21
Neurodyn Life Sciences Inc – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Neurodyn Life Sciences Inc, Pharmaceuticals & Healthcare, Key Facts 2
Neurodyn Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Neurodyn Life Sciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Neurodyn Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Neurodyn Life Sciences Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Neurodyn Life Sciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Neurodyn Acquires Memogain Related Assets From Galantos Pharma 10
Neurodyn Cognition Raises USD0.2 Million in Venture Financing 11
Neurodyn Cognition Raises USD0.4 Million in Venture Financing 12
Neurodyn Raises USD0.4 Million Financing 13
Neurodyn Life Sciences Raises Funds Through Venture Financing 14
Neurodyn Life Sciences Raises USD0.6 Million in Venture Financing 15
Neurodyn Life Sciences Raises USD0.3 Million in Venture Financing 16
Neurodyn Raises US$1.5 Million In Series A Financing 17
Neurodyn Raises US$0.13 Million In Venture Financing 18
Neurodyn Raises USD0.8 Million in Private Placement of Shares 19
Neurodyn Life Sciences Inc, Key Competitors 20
Neurodyn Life Sciences Inc, Key Employees 21
Neurodyn Life Sciences Inc, Subsidiaries 22

List of Figures
Neurodyn Life Sciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Neurodyn Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Neurodyn Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Neurodyn Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Neurodyn Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Neurodyn Life Sciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Neurodyn Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Neurodyn Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Neurodyn Life Sciences Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Solargiga Energy Holdings Ltd (757):電力:M&Aディール及び事業提携情報
    Summary Solargiga Energy Holdings Ltd (Solargiga Energy), a subsidiary of Wafer Works Corp is a renewable energy equipment manufacturer that develops and markets monocrystalline silicon products. The company manufactures monocrystalline silicon solar ingots and wafers, solar cells and photovoltaic m …
  • GAIL (India) Ltd (GAIL)
    GAIL (India) Ltd (GAIL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Oil India Ltd (OIL):石油・ガス:M&Aディール及び事業提携情報
    Summary Oil India Ltd (OIL) is an integrated upstream petroleum company which explores, develops, and produces crude oil and natural gas. It has petroleum exploration licenses in India; and exploration and production blocks across Venezuela, Gabon, Myanmar, Nigeria, Libya, Mozambique, Bangladesh, th …
  • BRF SA:企業の戦略・SWOT・財務分析
    BRF SA - Strategy, SWOT and Corporate Finance Report Summary BRF SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • The Scripps Research Institute:企業のM&A・事業提携・投資動向
    The Scripps Research Institute - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The Scripps Research Institute Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Forma Therapeutics Inc:企業のM&A・事業提携・投資動向
    Forma Therapeutics Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Forma Therapeutics Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • BDO International Limited:企業の戦略・SWOT・財務分析
    BDO International Limited - Strategy, SWOT and Corporate Finance Report Summary BDO International Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • System Dynamics International Incorporated:企業の戦略・SWOT・財務分析
    System Dynamics International Incorporated - Strategy, SWOT and Corporate Finance Report Summary System Dynamics International Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Valener Inc (VNR):石油・ガス:M&Aディール及び事業提携情報
    Summary Valener Inc (Valener) is an investment holding company that focuses on the energy sector. Through its investments in energy portfolio, the company offers storage, distribution, transportation and allied energy services. The company has interest in Gaz Metro and is its limited partner. Gaz Me …
  • Oracle Financial Services Software Limited (OFSS):企業の財務・戦略的SWOT分析
    Oracle Financial Services Software Limited (OFSS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Cosan S.A. Industria e Comercio (CSAN3)-エネルギー分野:企業M&A・提携分析
    Summary Cosan S.A. Industria e Comercio (Cosan), a subsidiary of Cosan Limited, is an integrated bioenergy company. It invests in diversified industries, including agribusiness, fuel and natural gas distribution, and lubricants. The company distributes lubricants, fuel oil, and piped natural gas; an …
  • European Bank for Reconstruction and Development:企業のM&A・事業提携・投資動向
    European Bank for Reconstruction and Development - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's European Bank for Reconstruction and Development Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business descri …
  • Japan Logistics Fund, Inc. :企業の戦略・SWOT・財務情報
    Japan Logistics Fund, Inc. - Strategy, SWOT and Corporate Finance Report Summary Japan Logistics Fund, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • CAS Medical Systems Inc (CASM):医療機器:M&Aディール及び事業提携情報
    Summary CAS Medical Systems Inc (CASMED) is a medical device company that designs, manufactures and markets technologies and monitors. The company offers technologies and monitors that deliver patient data. Its products comprise FORE-SIGHT absolute tissue oximeter, blood pressure measurement technol …
  • Z Energy Ltd
    Z Energy Ltd - Strategy, SWOT and Corporate Finance Report Summary Z Energy Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • PGS ASA (PGS):企業の財務・戦略的SWOT分析
    PGS ASA (PGS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Tokyo Electron Ltd (8035):企業の財務・戦略的SWOT分析
    Tokyo Electron Ltd (8035) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Sartorius AG (SRT):企業の財務・戦略的SWOT分析
    Sartorius AG (SRT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Kinnov Therapeutics SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary Kinnov Therapeutics SAS (Kinnov) is a research and development company that discovers and develops therapies against addiction. The company provides pipeline product such as KT-110, a pharmaceutical composition used as a therapy for addiction diseases. Its antagonist of alpha1-adrenergic rec …
  • Intersurgical Ltd.:企業の戦略的SWOT分析
    Intersurgical Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆